Keyphrases
Rifampicin
100%
Pulmonary Tuberculosis
100%
Randomized Trial
100%
Increased Dose
27%
Lung
27%
Tuberculosis
27%
Treatment Duration
24%
Treatment Costs
20%
Pyrazinamide
16%
Treatment Course
15%
New Drugs
15%
Sputum
12%
High Dose
12%
Pulmonary TB Patients
8%
Cost Reduction
7%
Highly Effective
7%
Blood Test
7%
Tuberculosis Transmission
7%
Ethambutol
7%
Economic Activity
7%
Treatment Failure
7%
Selling
7%
Bacillus
7%
Short-term Treatment
7%
Drug Combination
7%
Phase II Trial
7%
Treatment Allocation
7%
Consent Forms
7%
Treatment Services
7%
Microscopic Examination
7%
Bacterial Drug Resistance
7%
Liver Damage
7%
Cover Cost
7%
Quinolones
7%
Treatment Shortening
7%
Tuberculosis Bacteria
7%
Human Tuberculosis
7%
World Countries
7%
Treatment Facilities
7%
World Health Organization
7%
Relapse Rate
7%
Rifamycin
7%
Newly Diagnosed
7%
Transmission Rate
7%
Multiple Dose
7%
Pharmacology, Toxicology and Pharmaceutical Science
Rifampicin
100%
Lung Tuberculosis
100%
Pyrazinamide
17%
Disease
13%
Combination Drug
8%
Drug Resistance
8%
Bacilli
8%
Microscopy
8%
Mycobacterium Tuberculosis
8%
Quinolone Derivative
8%
Isoniazid Plus Rifampicin
8%
Ethambutol
8%
Isoniazid
8%
Side Effect
8%
Liver Injury
8%
Recurrence Risk
8%
Rifamycin
8%
Nursing and Health Professions
Lung Tuberculosis
66%
Rifampicin
66%
Treatment Duration
19%
Pyrazinamide
14%
World Health Organization
14%
Drug Megadose
9%
Disease
9%